Patient Access Solutions, Inc. (PASO)
OTCMKTS · Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
At close: Feb 6, 2026

Patient Access Solutions Income Statement

Millions USD. Fiscal year is Nov - Oct.
Fiscal Year
FY 2017FY 2016FY 2011FY 2010FY 2008
Period Ending
Oct '17 Oct '16 Oct '11 Oct '10 Oct '08
1.820.041.040.980.35
Revenue Growth (YoY)
4592.29%-96.26%5.81%179.90%8.60%
Cost of Revenue
0.03-00.40.26
Gross Profit
1.790.041.030.580.09
Selling, General & Admin
1.5-0.920.917.93
Other Operating Expenses
0.090.02-0.01-
Operating Expenses
1.60.020.960.978.04
Operating Income
0.190.020.07-0.39-7.96
Interest Expense
-0.06-0.01-0.01-0.03-0.08
Other Non Operating Income (Expenses)
-1.8--0.01-0.15-1.06
Pretax Income
-1.670.010.05-0.58-9.09
Income Tax Expense
---0-
Net Income
-1.670.010.05-0.58-9.09
Net Income to Common
-1.670.010.05-0.58-9.09
Net Income Growth
--86.63%---
Shares Outstanding (Basic)
20121-0
Shares Outstanding (Diluted)
20121-0
Shares Change (YoY)
67.32%754.25%--18.73%
EPS (Basic)
-0.080.000.03--182.07
EPS (Diluted)
-0.080.000.03--182.07
EPS Growth
--98.44%---
Free Cash Flow
-0.90.022.61--3.21
Free Cash Flow Per Share
-0.040.001.83--64.24
Gross Margin
98.18%100.00%99.57%59.47%24.39%
Operating Margin
10.56%51.99%7.05%-39.87%-2270.88%
Profit Margin
-91.47%16.83%4.71%-58.74%-2594.39%
Free Cash Flow Margin
-49.53%51.99%251.75%--915.40%
EBITDA
--0.12--7.85
EBITDA Margin
--11.37%--
D&A For EBITDA
--0.04-0.11
EBIT
0.190.020.07-0.39-7.96
EBIT Margin
10.56%51.99%7.05%-39.87%-
Revenue as Reported
--1.040.980.35
Advertising Expenses
0.07----
Source: S&P Global Market Intelligence. Standard template. Financial Sources.